Standardmäßig ist der Prompt ausgewählt, der zuerst die Quelle prüft. Sie können zu einem direkten Befehl wechseln oder eine lokale Kopie herunterladen.
Quelldateien prüfen
Lesen Sie SKILL.md und alle von SkillsMP angezeigten Begleitdateien, bevor Sie sich für eine Installation entscheiden.
Mit Codex oder Claude installieren Kopieren Sie diesen Prompt, fügen Sie ihn in Codex, Claude oder einen anderen Assistant ein und lassen Sie die Skill-Seite prüfen und installieren.
Ein direkter Befehl überspringt den Prüf-Prompt. Prüfen Sie die Quelle, bevor Sie ihn ausführen.
Report to FDA: At 2-week, 4-week, and 8-week intervals (or as directed).
Non-responsive escalation: Repeated contact → certified mail with return receipt → personal visit → notify FDA.
7. Product Disposition
Option
When
Requirements
Destruction
Contamination, fundamental defects (default)
Witnessed, certificate (date/method/qty/lots), photo/video for high-value
Reconditioning
Correctable defect; FDA pre-approval
Detailed proposal, QC verification per unit, batch records
Relabeling
Labeling-only; FDA pre-approval
Proposal, per-unit verification, records
Return to mfg
Evaluation/rework
Full chain of custody
Storage: Segregated, restricted access, conspicuously marked, full inventory controls.
Accountability: Periodic reconciliation of distributed vs. returned vs. disposed quantities. Investigate discrepancies. Prevent unauthorized re-entry into distribution.
8. Recall Termination
FDA decides termination, not the company. Never unilaterally declare completion or make public statements suggesting recall has concluded without written FDA agreement.
- [ ] Final effectiveness check results (% accounted for)
- [ ] Quantity reconciliation with explanations for gaps
- [ ] Complete disposition records
- [ ] All recall notifications/communications
- [ ] Outcome summary with lessons learned
- [ ] Formal termination request
9. Post-Recall Review
Monitoring: Handle recalled product surfacing after termination; notify FDA if significant quantities found.
Retention: Complete recall file minimum 2 years beyond termination (longer per litigation holds).
Review checklist:
- [ ] Timeliness of initial HHE
- [ ] Adequacy of recall strategy and mid-course adjustments
- [ ] Effectiveness of notifications
- [ ] Efficiency of recovery and disposition
- [ ] Resource and personnel adequacy
- [ ] Plan gaps identified
- [ ] Root cause / systemic quality issues
Produce written report with CAPA recommendations tracked through QMS.
Pitfalls
Never self-terminate: Only FDA can authorize recall completion
Classification is FDA's call: Company proposes; FDA assigns final classification
Reconditioning/relabeling require pre-approval: Do not proceed without FDA authorization
Guidance evolves: Flag sections with [VERIFY CURRENT GUIDANCE] where FDA guidance may have changed
Cross-reference requirements: Medical devices — MDR reporting (21 CFR Part 803) [VERIFY]; Drugs/biologics — field alert reporting (21 CFR 314.81) [VERIFY]
International distribution: Coordinate with foreign regulatory authorities if distributing outside the US
Dual audience: Maintain legal precision for counsel while keeping operational sections accessible to non-legal staff